Benjamin Carter

Benjamin Carter

Auto-generated profile, based on publicly available information

Benjamin Carter

Laboratory of Epigenome Biology, Systems Biology Center, National Heart, Lung and Blood Institute, NIH, Bethesda, MD, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2020 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
BCBenjamin Carter
Benjamin Carter
KZKeji Zhao
Keji Zhao

25 May 2018 in The Plant Cell
Verified
Journal Article
Open access
PDF file
BCBenjamin Carter
Benjamin Carter
BBBrett Bishop
Brett Bishop
KHKwok Ki Ho
Kwok Ki Ho
RHRu Huang
Ru Huang
WJWei Jia
Wei Jia
JOJoe Ogas
Joe Ogas
The chromatin remodelers PKL and PIE1 and the histone methyltransferase CLF act in an epigenetic pathway that promotes and maintains the repressive epigenetic m

20 August 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
BCBenjamin Carter
Benjamin Carter
WKWai Lim Ku
Wai Lim Ku
JKJee Youn Kang
Jee Youn Kang
Gangqing HuGangqing Hu
Gangqing Hu
JPJonathan Perrie
Jonathan Perrie
KZKeji Zhao
Keji Zhao
Modern next-generation sequencing-based methods have empowered researchers to assay the epigenetic states of individual cells. Existing techniques for profiling epigenetic marks in single cells often require the use and optimization of time-intensive procedures such as drop fluidics, chromatin fragmentation, and end repair. Here we describe ACT-seq, a streamlined method for mapping genome-wide distributions of histone tail modifications, histone variants, and chromatin-binding proteins in a small number of or single cells. ACT-seq utilizes a fusion of Tn5 transposase to Protein A that is targeted to chromatin by a specific antibody, allowing chromatin fragmentation and sequence tag insertion specifically at genomic sites presenting the relevant antigen. The Tn5 transposase enables the use of an index multiplexing strategy (iACT-seq), which enables construction of thousands of single-cell libraries in one day by a single researcher without the need for drop-based fluidics or visual sorting. We conclude that ACT-seq present an attractive alternative to existing techniques for mapping epigenetic marks in single cells.

1 December 2018 in Cell Chemical Biology
Verified
Journal Article
Closed access
CMChristine A. Marian
Christine A. Marian
MSMateusz Stoszko
Mateusz Stoszko
LWLili Wang
Lili Wang
MLMatthew W. Leighty
Matthew W. Leighty
ECElisa de Crignis
Elisa de Crignis
EDEmily Dykhuizen
Emily Dykhuizen

16 June 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
HKHiroaki Kikuchi
Hiroaki Kikuchi
CCChung-Lin Chou
Chung-Lin Chou
CYChin-Rang Yang
Chin-Rang Yang
LCLihe Chen
Lihe Chen
HJHyun Jun Jung
Hyun Jun Jung
MKMark A. Knepper
Mark A. Knepper
Loss of a kidney results in compensatory growth of the remaining kidney, a phenomenon of considerable clinical importance. However, the mechanisms involved are largely unknown. Here, we use a multi-omic approach in a unilateral nephrectomy model in male mice to identify signaling processes associated with renal compensatory hypertrophy, demonstrating that the lipid-activated transcription factor peroxisome proliferator-activated receptor alpha (PPARα) is an important determinant of proximal tubule cell size and is a likely mediator of compensatory proximal tubule hypertrophy.

1 May 2019 in iScience
Verified
Journal Article
Open access
EPElizabeth G. Porter
Elizabeth G. Porter
ADAlisha Dhiman
Alisha Dhiman
BCBasudev Chowdhury
Basudev Chowdhury
BCBenjamin C. Carter
Benjamin C. Carter
HLHang Lin
Hang Lin
EDEmily Dykhuizen
Emily Dykhuizen
Polybromo1 (PBRM1) is a chromatin remodeler subunit highly mutated in cancer, particularly clear cell renal carcinoma. PBRM1 is a member of the SWI/SNF subcomplex, PBAF (PBRM1-Brg1/Brm-associated factors), and is characterized by six tandem bromodomains. Here we establish a role for PBRM1 in epithelial cell maintenance through the expression of genes involved in cell adhesion, metabolism, stress response, and apoptosis. In support of a general role for PBRM1 in stress response and apoptosis, we observe that loss of PBRM1 results in an increase in reactive oxygen species generation and a decrease in cellular viability under stress conditions. We find that loss of PBRM1 promotes cell growth under favorable conditions but is required for cell survival under conditions of cellular stress.